Lower Blepharoplasty Medical Services in China

Lower eyelid blepharoplasty, commonly known as lower eyelid surgery or “tear-trough correction,” is a cosmetic and functional oculoplastic procedure designed to address age-related or congenital lower eyelid deformities—including fat prolapse, skin laxity, orbital hollowing, and prominent tear troughs. These changes often result in a tired, aged, or shadowed appearance beneath the eyes and may occasionally impair vision or cause discomfort due to excessive skin or ectropion. The surgery typically involves conservative fat repositioning or selective fat removal, combined with skin and orbicularis muscle refinement, aiming to restore youthful contour while preserving natural anatomy and ocular function. It is distinct from upper blepharoplasty and requires precise anatomical knowledge of the orbital septum, infraorbital fat compartments, and lower lid support structures to avoid complications such as scleral show, lid malposition, or hollowing. Candidates are generally adults over 30 with stable health, realistic expectations, and no active ocular disease. Preoperative assessment includes detailed facial analysis, lid laxity testing, and evaluation of tear film integrity.

China offers compelling advantages for lower eyelid blepharoplasty: highly trained oculoplastic surgeons—many fellowship-trained in Korea, Japan, or the U.S.—operate in JCI-accredited hospitals equipped with advanced imaging (e.g., 3D facial scanning) and minimally invasive platforms. Costs are typically 40–60% lower than in Western countries without compromising safety or outcomes. Chinese centers report high patient satisfaction (>92% in published cohort studies), with notable success in complex revisions and Asian-specific anatomical adaptations—such as managing thicker orbicularis muscle and flatter orbital rims. Leading institutions like Shanghai Ninth People’s Hospital and Beijing Tongren Hospital have published peer-reviewed outcomes demonstrating low complication rates (<2.5%) and long-term aesthetic stability.

Treatment Options & Itemized Cost Breakdown: Lower Blepharoplasty (Plastic Surgery Department)

Non-Surgical / Conservative Management

*Indicated for mild pseudoherniation, early fat prolapse without skin excess, or patients contraindicated for surgery.*

• •Topical Hyaluronic Acid + Peptide Creams (e.g., prescription-grade formulations): ¥180–¥320/month ($25–$45)
• •Radiofrequency Microneedling (3 sessions): Pre-treatment consultation ¥120 ($17), per session ¥1,600–¥2,400 ($225–$335), post-care serum ¥280 ($39)
• •Ultrasound-Guided Focused RF (1–2 sessions): Baseline ultrasound imaging ¥300 ($42), per session ¥2,800–¥4,200 ($390–$585)
• •*Lab/Exam Fees*: CBC, coagulation panel, liver/kidney function (required for RF eligibility): ¥260 ($36)

Surgical / Procedural Options

*Eligibility: Adults ≥18 years, stable weight, no uncontrolled hypertension/diabetes, no active dermatitis or keloid history. Performed exclusively in Plastic Surgery Department.*

• •Transconjunctival Fat Repositioning (no skin incision):

- Procedure fee: ¥12,800–¥18,500 ($1,780–$2,570)

• •Skin-Muscle Flap Approach with Fat Removal/Repositioning:

- Procedure fee: ¥16,200–¥24,600 ($2,250–$3,420)

• •Combined Lower Blepharoplasty + Midface Lift (for severe descent):

- Procedure fee: ¥32,800–¥47,500 ($4,560–$6,600)

Special / Complex Condition Management

• •Revision Surgery (post-scar contracture, asymmetry, hollowing): Pre-op 3D surface imaging ¥600 ($84), procedure ¥28,000–¥41,200 ($3,900–$5,730)
• •Lymphedema-Associated Bags (confirmed via lymphoscintigraphy): Lymphoscintigraphy ¥1,200 ($167), surgical debulking + liposuction ¥36,500–¥52,000 ($5,070–$7,230)
• •Neurofibromatosis-Related Bag Deformity: MRI brain/orbit (plastic surgery protocol): ¥980 ($136), staged resection/reconstruction: ¥44,000–¥68,000 ($6,120–$9,450)

Quick Selection Guide

• •Age <35, Mild Fullness, Budget <$2,000: Start with RF microneedling (3 sessions: ~$750 total).
• •Age 35–55, Moderate Fat Prolapse + Mild Skin Laxity, No Comorbidities: Transconjunctival repositioning ($1,900–$2,700) — optimal balance of efficacy and recovery.
• •Age >55, Severe Skin Excess + Orbital Volume Loss, Controlled Hypertension: Skin-muscle flap with fat repositioning ($2,400–$3,600); pre-op ECG/X-ray mandatory.
• •Revision Cases or NF1/Lymphedema: Require multidisciplinary plastic surgery evaluation; budget $5,000–$9,500 minimum.
• •Comorbidities (uncontrolled DM, anticoagulant use): Conservative RF or topical therapy only until medical optimization achieved.